CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	January 2024 [Member]	August 2024 [Member]	Common Stock	Common Stock January 2024 [Member]	Common Stock August 2024 [Member]	Additional Paid In Capital	Additional Paid In Capital January 2024 [Member]	Additional Paid In Capital August 2024 [Member]	Accumulated Deficit	Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2022	$ 490,151			$ 6			$ 878,884			$ (383,790)	$ (4,949)
Shares, Outstanding, Beginning Balance at Dec. 31, 2022				55,039,380
Issuance of common stock and accompanying pre-funded warrants from public offering, net of issuance costs	0
Issuance of common stock and accompanying pre-funded warrants from August 2024 public offering, net of issuance costs of $12.2 million	0
Exercise of stock options	2,297						2,297
Exercise of stock options, Shares				335,065
Vesting restricted stock, Shares				36,371
Issuance of shares under employee stock purchase plan	962						962
Issuance of shares under employee stock purchase plan, Shares				39,423
Stock-based compensation expense	32,220						32,220
Unrealized loss on marketable securities	2,499										2,499
Net loss	(132,594)									(132,594)
Ending Balance at Sep. 30, 2023	395,535			$ 6			914,363			(516,384)	(2,450)
Shares, Outstanding, Ending Balance at Sep. 30, 2023				55,450,239
Beginning Balance at Jun. 30, 2023	435,428			$ 6			902,574			(463,517)	(3,635)
Shares, Outstanding, Beginning Balance at Jun. 30, 2023				55,390,259
Exercise of stock options	135						135
Exercise of stock options, Shares				58,373
Vesting restricted stock, Shares				1,607
Stock-based compensation expense	11,654						11,654
Unrealized loss on marketable securities	1,185										1,185
Net loss	(52,867)									(52,867)
Ending Balance at Sep. 30, 2023	395,535			$ 6			914,363			(516,384)	(2,450)
Shares, Outstanding, Ending Balance at Sep. 30, 2023				55,450,239
Beginning Balance at Dec. 31, 2023	394,971			$ 6			926,269			(530,752)	(552)
Shares, Outstanding, Beginning Balance at Dec. 31, 2023				55,585,305
Issuance of common stock and accompanying pre-funded warrants from public offering, net of issuance costs	(301,373)	$ 301,373	$ 246,506			$ 1		$ 301,373	$ 246,505
Issuance of common stock through At-The Market Sales Agreement, net of issuance costs of $1.2 million, Share				1,519,453
Issuance of common stock through at-the market sales agreement, net of issuance costs	48,740						48,740
Issuance of common stock and accompanying pre-funded warrants from August 2024 public offering, net of issuance costs of $12.2 million	(246,506)
Issuance of common stock and accompanying pre-funded warrants, shares					3,884,158	2,830,533
Exercise of stock options	9,616						9,616
Exercise of stock options, Shares				695,821
Vesting restricted stock, Shares				168,731
Issuance of shares under employee stock purchase plan	1,134						1,134
Issuance of shares under employee stock purchase plan, Shares				64,225
Stock-based compensation expense	41,213						41,213
Unrealized loss on marketable securities	2,483										2,483
Net loss	(153,106)									(153,106)
Ending Balance at Sep. 30, 2024	892,930			$ 7			1,574,850			(683,858)	1,931
Shares, Outstanding, Ending Balance at Sep. 30, 2024				64,748,226
Beginning Balance at Jun. 30, 2024	684,924			$ 6			1,308,388			(621,371)	(2,099)
Shares, Outstanding, Beginning Balance at Jun. 30, 2024				61,572,383
Issuance of common stock and accompanying pre-funded warrants from public offering, net of issuance costs			$ 246,506			$ 1			$ 246,505
Issuance of common stock and accompanying pre-funded warrants, shares				2,830,533
Exercise of stock options	5,053						5,053
Exercise of stock options, Shares				340,482
Vesting restricted stock, Shares				4,828
Stock-based compensation expense	14,904						14,904
Unrealized loss on marketable securities	4,030										4,030
Net loss	(62,487)									(62,487)
Ending Balance at Sep. 30, 2024	$ 892,930			$ 7			$ 1,574,850			$ (683,858)	$ 1,931
Shares, Outstanding, Ending Balance at Sep. 30, 2024				64,748,226